FDA Import Refusal UPS-4163872-8/11/1 — Astellas Pharma Inc.
The FDA refused shipment UPS-4163872-8/11/1 from Astellas Pharma Inc. (Japan) on July 17, 2017. The refused product falls under Drugs and Biologics — TACROLIMUS (IMMUNOSUPPRESSIVE). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 17, 2017
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 64TCE08 TACROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 118,3280,75